Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47,749 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Three-year follow-up and patient-reported outcomes from CheckMate 078: Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer.
Chang J, Wu YL, Lu S, Wang J, Mok T, Zhang L, Feng J, Wu L, Tu HY, Zhang Y, Luft A, Zhou JY, Ma Z, Lu Y, Hu C, Shi Y, Poddubskaya E, Soo RA, Chia YH, Penrod JR, Taylor F, Lawrance R, Blum SI, Sun X, Juarez-Garcia A, Moreno-Koehler A, Li A, Li A, Cheng Y. Chang J, et al. Among authors: lu y, lu s. Lung Cancer. 2022 Mar;165:71-81. doi: 10.1016/j.lungcan.2021.12.009. Epub 2021 Dec 27. Lung Cancer. 2022. PMID: 35093625
Chinese guidelines on the diagnosis and treatment of primary lung cancer (2011).
Zhi XY, Wu YL, Bu H, Cheng G, Cheng Y, Du X, Han BH, Jiang GN, Jiao SC, Liu DR, Liu LX, Lu Y, Ma SL, Shi YK, Wang CL, Wang J, Wang TY, Yang Y, Zhou QH; Lung Cancer Diagnosis and Treatment Expert Panel of the Chinese Ministry of Health. Zhi XY, et al. Among authors: lu y. J Thorac Dis. 2012 Feb;4(1):88-101. doi: 10.3978/j.issn.2072-1439.2010.08.01. J Thorac Dis. 2012. PMID: 22295172 Free PMC article. No abstract available.
[A randomized, controlled, multicenter clinical trial comparing pemetrexed/cisplatin and gemcitabine/cisplatin as first-line treatment for advanced nonsquamous non-small cell lung cancer].
Huang Y, Liu Y, Zhou J, Xu N, Li B, Wu G, Fang J, Li K, Liu X, Liu W, Lu Y, Wang M, Liu W, Liang H, Zhang Y, Huang C, Wang S, Wang Y, Yu S, Chang J, Wang Z, Hu Z, Zhang L. Huang Y, et al. Among authors: lu y. Zhongguo Fei Ai Za Zhi. 2012 Oct;15(10):576-82. doi: 10.3779/j.issn.1009-3419.2012.10.03. Zhongguo Fei Ai Za Zhi. 2012. PMID: 23075681 Free PMC article. Clinical Trial. Chinese.
[Chinese guidelines on the diagnosis and treatment of primary lung cancer 
(2011 version)].
Zhi X, Wu Y, Ma S, Wang T, Wang C, Wang J, Shi Y, Lu Y, Liu L, Liu D, Chen D, Yang Y, Du X, Bu H, Zhou Q, Jang G, Han B, Cheng G, Cheng Y, Jiao S. Zhi X, et al. Among authors: lu y. Zhongguo Fei Ai Za Zhi. 2012 Dec;15(12):677-88. doi: 10.3779/j.issn.1009-3419.2012.12.01. Zhongguo Fei Ai Za Zhi. 2012. PMID: 23249713 Free PMC article. Chinese. No abstract available.
47,749 results
You have reached the last available page of results. Please see the User Guide for more information.